Bayer, Syngenta, Elanco Animal Health and Alexandria Real Estate Equities were among the investors as fungicide developer Boragen launched with $10m of funds.
US-based fungicide developer Boragen has launched with $10m of series A funding from investors including agribusinesses Bayer and Syngenta, the latter participating through its Syngenta Ventures unit.
Alexandria Venture Investments, the VC arm of real estate firm Alexandria Real Estate Equities, animal health product maker Elanco, Arch Venture Partners, Bill & Melinda Gates Foundation, Flagship Pioneering, Hatteras Venture Partners, Mountain Group Capital and Pappas Capital also took part in the round.
Boragen is the first company to be launched by accelerator…
